Add-on Acquisition • Life Science

Compass Therapeutics Acquires TRIGR Therapeutics

On May 13, 2021, Compass Therapeutics acquired life science company TRIGR Therapeutics

Acquisition Context

This is Compass Therapeutics’ 1st transaction in the Life Science sector.
This is Compass Therapeutics’ 1st transaction in the United States.
This is Compass Therapeutics’ 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	May 13, 2021
Target	TRIGR Therapeutics
Sector	Life Science
Buyer(s)	Compass Therapeutics
Deal Type	Add-on Acquisition

Target Company

TRIGR Therapeutics

Irvine, California, United States

TRIGR Therapeutics a private biotechnology oncology company in the field of multi-targeted cancer therapies. TRIGR Therapeutics portfolio of bispecific antibodies includes major mechanisms known to disrupt/halt tumor/ stem cell proliferation (anti-angiogenesis) and activate the immune response (4-1BB engagers) within a single molecule. TRIGR Therapeutics was founded in 2018 and is based in Irvine, California.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Compass Therapeutics

Boston, United Kingdom

Category	Company
Founded	2014
Sector	Life Science
Employees	35

DESCRIPTION

Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain-based multispecific platforms to empirically identify multispecific and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. Compass Therapeutics was incorporated in 2014 and is based in Boston, Massachusetts.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2021 M&A